Trials
Search / Trial NCT05652764

Orem's Self-Care Deficit Theory Based Nursing Interventions for Immunotherapy Treated Cancer Patients

Launched by AKDENIZ UNIVERSITY · Dec 14, 2022

Trial Information

Current as of January 14, 2025

Completed

Keywords

Cancer Immunotherapy Treatment Side Effects Symptom Management Self Care Deficiency Care Needs Oncology Nursing

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Coming to Antalya Training and Research Hospital Medical Oncology unit for treatment,
  • First time taking one of the immune checkpoint inhibitors (Ipilimumab CTLA-4, Pembrolizumab PD-1, Nivolumab PD-1, Atezolizumab PDL-1),
  • Speaking and understanding Turkish,
  • Being literate,
  • 18 Years and older
  • With solid tumor,
  • No communication barrier
  • Being able to communicate by phone
  • Individuals who agree to participate in the research.
  • Exclusion Criteria:
  • Patients receiving other cancer treatments in combination with immunotherapy,
  • Patients with Eastern Cooperative Oncology Group Performance Scale 4.

Trial Officials

Fatma Arikan

Study Director

Akdeniz University

About Akdeniz University

Akdeniz University is a leading academic institution located in Antalya, Turkey, renowned for its commitment to advancing medical research and education. As a clinical trial sponsor, Akdeniz University leverages its extensive expertise and state-of-the-art facilities to facilitate innovative research initiatives aimed at improving patient outcomes. The university collaborates with a diverse range of stakeholders, including healthcare professionals, researchers, and industry partners, to conduct rigorous clinical trials that adhere to the highest ethical and scientific standards. Through its dedication to excellence in research, Akdeniz University plays a pivotal role in contributing to the development of new therapies and enhancing the understanding of various medical conditions.

Locations

Antalya, , Turkey

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0

Similar Trials